Market Overview

UPDATE: JP Morgan Raises PT to $55 on CME Group on Competitive Positioning

Related CME
S&P 500 Hits 2,000 Milestone As Bullish Momentum Continues
Thursday's Selling Momentum Continues Into Friday
CME Glitch Halts Electronic Trading in Some Commodities (Fox Business)

JP Morgan reiterated its Underweight rating on CME Group (NASDAQ: CME) but raised its price target from $54 to $55.

JP Morgan noted, "CME is a high quality company, in our view, with high margins, strong cash flow generation, and strong competitive positioning. However, we don't expect that CME's stock will continue to outperform peers', given deteriorating fundamentals and perhaps loftier expectations of the OTC clearing opportunity than we think are realistic. The issue is that the core businesses continue to face headwinds and Wall Street estimates continue to move downwards reflecting this, but the stock keeps moving higher. The risk to the upside, in our mind, is that a potential QE3 lifts volumes in the short term, although looking at past periods of quantitative easing, volume increases have not appeared to be sustainable."

CME Group closed at $57.10 on Tuesday.

Posted-In: JP MorganAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters